Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 247 followers
Latest posts
Last updated about 7 hours ago
Orphan designation: Autologous haematopoietic cells genetically modified with a lentiviral vector containing the human gp91(phox) gene Treatment of X-linked chronic granulomatous disease, 09/02/2012 Positive
9 days ago
Orphan designation: Autologous haematopoietic cells genetically modified with a lentiviral vector containing...
Guidance on the application of the amended Variations Regulation from 1 January 2025
about 17 hours ago
Guidance on the application of the amended Variations Regulation from 1 January...
Human medicines European public assessment report (EPAR): Tibsovo, ivosidenib, Date of authorisation: 04/05/2023, Revision: 3, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Tibsovo, ivosidenib, Date of authorisation...
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 October 2024
about 18 hours ago
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 October 2024
Human medicines European public assessment report (EPAR): Leflunomide ratiopharm, leflunomide, Date of authorisation: 28/11/2010, Revision: 18, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Leflunomide ratiopharm, leflunomide, Date of...
Human medicines European public assessment report (EPAR): Pregabalin Accord, pregabalin, Date of authorisation: 28/08/2015, Revision: 18, Status: Authorised
about 19 hours ago
Human medicines European public assessment report (EPAR): Pregabalin Accord, pregabalin, Date of...
Human medicines European public assessment report (EPAR): Sugammadex Adroiq, sugammadex, Date of authorisation: 26/05/2023, Revision: 3, Status: Authorised
about 19 hours ago
Human medicines European public assessment report (EPAR): Sugammadex Adroiq, sugammadex, Date of...